Literature DB >> 2742831

Posttranslational modification of hepatic cytochrome P-450. Phosphorylation of phenobarbital-inducible P-450 forms PB-4 (IIB1) and PB-5 (IIB2) in isolated rat hepatocytes and in vivo.

J A Koch1, D J Waxman.   

Abstract

Phosphorylation of hepatic cytochrome P-450 was studied in isolated hepatocytes incubated in the presence of agents known to stimulate protein kinase activity. Incubation of hepatocytes isolated from phenobarbital-induced adult male rats with [32P]orthophosphate in the presence of N6,O2'-dibutyryl-cAMP (diBtcAMP) or glucagon resulted in the phosphorylation of microsomal proteins that are immunoprecipitable by polyclonal antibodies raised to the phenobarbital-inducible P-450 form PB-4 (P-450 gene IIB1). Little or no phosphorylation of these proteins was observed in the absence of diBtcAMP or glucagon or in the presence of activators of Ca2+-dependent protein kinases. Two-dimensional gel electrophoresis revealed that these 32P-labeled microsomal proteins consist of a mixture of P-450 PB-4 and the closely related P-450 PB-5 (gene IIB2), both of which exhibited heterogeneity in the isoelectric focusing dimension. Phosphorylation of both P-450 forms was markedly enhanced by diBtcAMP at concentrations as low as 5 microM. In contrast, little or no phosphorylation of P-450 forms reactive with antibodies to P-450 PB-1 (gene IIC6), P-450 2c (gene IIC11), or P-450 PB-2a (gene IIIA1) was detected in the isolated hepatocytes under these incubation conditions. Phosphoamino acid analysis of the 32P-labeled P-450 PB-4 + PB-5 immunoprecipitate revealed that these P-450s are phosphorylated on serine in the isolated hepatocytes. Peptide mapping indicated that the site of phosphorylation in hepatocytes is indistinguishable from the site utilized by cAMP-dependent protein kinase in vitro, which was previously identified as serine-128 for the related rabbit protein P-450 LM2.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2742831     DOI: 10.1021/bi00434a005

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  8 in total

Review 1.  Phenobarbital induction of cytochrome P-450 gene expression.

Authors:  D J Waxman; L Azaroff
Journal:  Biochem J       Date:  1992-02-01       Impact factor: 3.857

Review 2.  Phosphorylation of cytochrome P450 isoenzymes in intact hepatocytes and its importance for their function in metabolic processes.

Authors:  B Oesch-Bartlomowicz; F Oesch
Journal:  Arch Toxicol       Date:  1990       Impact factor: 5.153

3.  Substrate-, hormone-, and cAMP-regulated cytochrome P450 degradation.

Authors:  E Eliasson; I Johansson; M Ingelman-Sundberg
Journal:  Proc Natl Acad Sci U S A       Date:  1990-04       Impact factor: 11.205

4.  Multisite phosphorylation of human liver cytochrome P450 3A4 enhances Its gp78- and CHIP-mediated ubiquitination: a pivotal role of its Ser-478 residue in the gp78-catalyzed reaction.

Authors:  YongQiang Wang; Shenheng Guan; Poulomi Acharya; Yi Liu; Ranjit K Thirumaran; Relly Brandman; Erin G Schuetz; Alma L Burlingame; Maria Almira Correia
Journal:  Mol Cell Proteomics       Date:  2011-11-17       Impact factor: 5.911

Review 5.  Hepatic cytochrome P450 ubiquitination: conformational phosphodegrons for E2/E3 recognition?

Authors:  Maria Almira Correia; YongQiang Wang; Sung-Mi Kim; Shenheng Guan
Journal:  IUBMB Life       Date:  2014-02-03       Impact factor: 3.885

6.  A role for protein phosphorylation in cytochrome P450 3A4 ubiquitin-dependent proteasomal degradation.

Authors:  Yongqiang Wang; Mingxiang Liao; Nicholas Hoe; Poulomi Acharya; Changhui Deng; Andrew N Krutchinsky; Maria Almira Correia
Journal:  J Biol Chem       Date:  2008-12-18       Impact factor: 5.157

7.  Phosphorylation of hepatic phenobarbital-inducible cytochrome P-450.

Authors:  W Pyerin; H Taniguchi
Journal:  EMBO J       Date:  1989-10       Impact factor: 11.598

8.  Mechanism-based predictions of interactions.

Authors:  F Oesch; B Oesch-Bartlomowicz; J Arens; F Fähndrich; E Vogel; T Friedberg; H Glatt
Journal:  Environ Health Perspect       Date:  1994-11       Impact factor: 9.031

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.